UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006497
Receipt number	R000007605
Scientific Title	A phase II trial of sequential treatment from cisplatin-etoposide therapy (PE) to irinotecan hydrochloride + amrubicin hydrochloride therapy with concomitant use of G-CSF nartograstim in patients with extensive-stage small cell lung cancer or advanced large cell neuroendocrine carcinoma (LCNEC)
Date of disclosure of the study information	2011/10/07
Last modified on	2011/10/05 21:04:02

---